Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus, Denmark.
Metab Brain Dis. 2011 Jun;26(2):135-9. doi: 10.1007/s11011-011-9242-1. Epub 2011 Apr 12.
Minimal hepatic encephalopathy (MHE) is intermittently present in up to 2/3 of patients with chronic liver disease. It impairs their daily living and can be treated. However, there is no consensus on diagnostic criteria except that psychometric methods are required. We compared two easy-to-perform reproducible bedside methods: the critical flicker frequency (CFF) and continuous reaction times (CRT) tests. A CFF <39 Hz and CRT-index <1.9 (index: the ratio 50/(90 minus 10) percentiles of reaction times) indicates cerebral dysfunction. 154 patients with acute or chronic liver disease with out overt hepatic encephalopathy (HE) underwent both tests at the same occasion. Both tests were abnormal in 20% of the patients and both tests were normal in 40% of the patients. In more than 1/3 the two tests were not in agreement as CFF classified 32% and CRT-index classified 48% of the patients as having MHE (p < 0.005). The two tests were weakly linearly correlated (r(2) = 0.14, p < 0.001) and neither test correlated with the metabolic liver function measured by the Galactose Elimination Capacity (GEC), nor with the blood ammonia concentration. Both tests identified a large fraction of the patients as having MHE and cleared only 40%. The two tests did not show concordant results, likely because they describe different aspects of MHE: the CFF gives a measure of astrocytic metabolic state and hence pathogenic aspects of MHE, whereas the CRT measures a composite key performance, viz. the ability of reacting appropriately to a sensory stimulus. The choice of test depends on the information needed in the clinical and scientific care and study of the patients.
轻微型肝性脑病(MHE)在多达 2/3 的慢性肝病患者中间歇性存在。它会损害他们的日常生活,可以进行治疗。然而,除了需要心理计量方法外,目前还没有关于诊断标准的共识。我们比较了两种易于执行且可重复的床边方法:临界闪烁频率(CFF)和连续反应时间(CRT)测试。CFF<39 Hz 和 CRT-index<1.9(指数:反应时间 50/(90 减去 10)百分位数的比值)表明存在大脑功能障碍。154 名患有急性或慢性肝病且无显性肝性脑病(HE)的患者在同一时间接受了这两种测试。20%的患者两种测试均异常,40%的患者两种测试均正常。在超过 1/3 的患者中,两种测试不一致,CFF 将 32%的患者和 CRT-index 将 48%的患者归类为患有 MHE(p<0.005)。两种测试呈弱线性相关(r²=0.14,p<0.001),且两种测试均与代谢肝功能(通过半乳糖消除能力(GEC)测量)或血氨浓度均无相关性。两种测试都将很大一部分患者归类为患有 MHE,但只能排除 40%的患者。两种测试并未显示出一致的结果,这可能是因为它们描述了 MHE 的不同方面:CFF 提供了星形胶质细胞代谢状态的衡量标准,因此反映了 MHE 的发病机制方面,而 CRT 则衡量了综合关键性能,即对感觉刺激做出适当反应的能力。测试的选择取决于患者临床和科学护理以及研究中所需的信息。